Relevance of chronic stress and the two faces of microglia in Parkinson's disease

Staging of brain pathology related to sporadic Parkinson’s disease

Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · see citing works

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · see citing works

Conflict monitoring and cognitive control

Botvinick, M. M., Braver, T. S., Barch, D. M., Carter, C. S., & Cohen, J. D. (2001) · Psychological Review · doi:10.1037/0033-295x.108.3.624 · Cited by 7,351 · see citing works

Parkinson's Disease

Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469 · see citing works

Physiology and neurobiology of stress and adaptation: central role of the brain

McEwen, B. S. (2007) · Physiological Reviews · doi:10.1152/physrev.00041.2006 · Cited by 4,981 · cited 1× · see citing works

α-Synuclein Locus Triplication Causes Parkinson's Disease

Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383 · see citing works

AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · see citing works

Physiological functions of glucocorticoids in stress and their relation to pharmacological actions

MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083 · see citing works

Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains

McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990 · see citing works

The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737 · see citing works

THE GENERAL ADAPTATION SYNDROME AND THE DISEASES OF ADAPTATION1

Selye, H. (1946) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-6-2-117 · Cited by 2,296 · see citing works

STRESS AND HIPPOCAMPAL PLASTICITY

McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · see citing works

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,646 · see citing works

Infiltration of CD4+ lymphocytes into the brain contributes to neurodegeneration in a mouse model of Parkinson disease

Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172 · see citing works

Mood disorders and allostatic load

McEwen, B. S. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00177-x · Cited by 1,135 · see citing works

Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct

Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127 · see citing works

Down-Regulation of the Macrophage Lineage Through Interaction with OX2 (CD200)

Hoek, R. M., Ruuls, S. R., Murphy, C. A., Wright, G. J., Goddard, R., Zurawski, S. M., Blom, B., Homola, M. E., Streit, W. J., Brown, M. H., et al. (2000) · Science · doi:10.1126/science.290.5497.1768 · Cited by 1,022 · see citing works

Dopamine controls systemic inflammation through inhibition of NLRP3 inflammasome

Yan, Y., Jiang, W., Liu, L., Wang, X., Ding, C., Tian, Z., & Zhou, R. (2015) · Cell · doi:10.1016/j.cell.2014.11.047 · Cited by 1,014 · see citing works

Action sets and decisions in the medial frontal cortex

RUSHWORTH, M., WALTON, M., KENNERLEY, S., & BANNERMAN, D. (2004) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2004.07.009 · Cited by 1,004 · see citing works

Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17

Hong, M. (1998) · Science · doi:10.1126/science.282.5395.1914 · Cited by 1,003 · see citing works

Neuroendocrine pharmacology of stress

Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914 · see citing works

Acute and chronic stress effects on open field activity in the rat: Implications for a model of depression

Katz, R. J., Roth, K. A., & Carroll, B. J. (1981) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(81)90005-1 · Cited by 889 · see citing works

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works

Pharmacological Actions of 6-Hydroxydopamine

Kostrzewa, R. M., & Jacobowitz, D. M. (1974) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06677-3 · Cited by 819 · see citing works

Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor-κB and Steroid Receptor-Signaling Pathways

McKay, L. I., & Cidlowski, J. A. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.4.0375 · Cited by 805 · see citing works

Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease

Hamza, T. H., Zabetian, C. P., Tenesa, A., Laederach, A., Montimurro, J. S., Yearout, D., Kay, D. M., Doheny, K. F., Paschall, J. E., Pugh, E., et al. (2010) · Nature Genetics · doi:10.1038/ng.642 · Cited by 779 · see citing works

New Insights into the Mechanism of Action of Amphetamines

Fleckenstein, A. E., Volz, T. J., Riddle, E. L., Gibb, J. W., & Hanson, G. R. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105140 · Cited by 731 · see citing works

G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome

Lesage, S., Anheim, M., Letournel, F., Bousset, L., Honoré, A., Rozas, N., Pieri, L., Madiona, K., Dürr, A., Melki, R., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23894 · Cited by 697 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's Disease

Volles, M. J., Lee, S., Rochet, J., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682 · see citing works

Cell-to-cell transmission of pathogenic proteins in neurodegenerative diseases

Guo, J. L., & Lee, V. M. Y. (2014) · Nature Medicine · doi:10.1038/nm.3457 · Cited by 641 · see citing works

β-Adrenergic Receptor Antagonism Prevents Anxiety-Like Behavior and Microglial Reactivity Induced by Repeated Social Defeat

Wohleb, E. S., Hanke, M. L., Corona, A. W., Powell, N. D., Stiner, L. M., Bailey, M. T., Nelson, R. J., Godbout, J. P., & Sheridan, J. F. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.0450-11.2011 · Cited by 638 · see citing works

Dopamine-modified α-synuclein blocks chaperone-mediated autophagy

Martínez‐Vicente, M., Tallóczy, Z., Kaushik, S., Massey, A. C., Mazzulli, J. R., Mosharov, E. V., Hodara, R., Fredenburg, R. A., Wu, D.-C., Follenzi, A., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32806 · Cited by 633 · see citing works

Methamphetamine toxicity and messengers of death

Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589 · see citing works

Neuroinflammation in Parkinson's disease

Hirsch, E. C., Vyas, S., & Hunot, S. (2012) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(11)70065-7 · Cited by 586 · see citing works

Triggering of inflammasome by aggregated α-synuclein, an inflammatory response in synucleinopathies

Codolo, G., Plotegher, N., Pozzobon, T., Brucale, M., Tessari, I., Bubacco, L., & de Bernard, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055375 · Cited by 585 · see citing works

Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses

Frank, M. G., Baratta, M. V., Sprunger, D. B., Watkins, L. R., & Maier, S. F. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.03.005 · Cited by 578 · see citing works

Neuroendocrinology and pathophysiology of the stress system

STRATAKIS, C. A., & CHROUSOS, G. P. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44666.x · Cited by 533 · see citing works

Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions

Tynan, R. J., Naicker, S., Hinwood, M., Nalivaiko, E., Buller, K. M., Pow, D. V., Day, T. A., & Walker, F. R. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2010.02.001 · Cited by 531 · see citing works

Depression and somatization: a review

Katon, W. J., Kleinman, A., & Rosen, G. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90816-6 · Cited by 530 · see citing works

Subordination stress: Behavioral, brain, and neuroendocrine correlates

Blanchard, D. C., Sakai, R. R., McEwen, B. S., Weiss, S. Μ., & Blanchard, R. J. (1993) · Behavioural Brain Research · doi:10.1016/0166-4328(93)90096-9 · Cited by 484 · see citing works

A novel α-synuclein missense mutation in Parkinson disease

Proukakis, C., Dudzik, C. G., Brier, T., Mackay, D. S., Cooper, J. A. D., Millhauser, G. L., Houlden, H., & Schapira, A. H. V. (2013) · Neurology · doi:10.1212/wnl.0b013e31828727ba · Cited by 465 · see citing works

An inflammatory review of glucocorticoid actions in the CNS

Sorrells, S. F., & Sapolsky, R. M. (2006) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.11.006 · Cited by 461 · see citing works

The Stressed CNS: When Glucocorticoids Aggravate Inflammation

Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425 · cited 2× · see citing works

Evidence that Microglia Mediate the Neurobiological Effects of Chronic Psychological Stress on the Medial Prefrontal Cortex

Hinwood, M., Morandini, J., Day, T. A., & Walker, F. R. (2012) · Cerebral Cortex · doi:10.1093/cercor/bhr229 · Cited by 420 · see citing works

Cytokines and neuro–immune–endocrine interactions: a role for the hypothalamic–pituitary–adrenal revolving axis

Haddad, J. J., Saadé, N. E., & Safieh‐Garabedian, B. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00357-0 · Cited by 416 · see citing works

Further studies of the role of hyperthermia in methamphetamine neurotoxicity.

Bowyer, J. F., Davies, D. L., Schmued, L. C., Broening, H. W., Newport, G. D., Slikker, W., & Holson, R. R. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38650-7 · Cited by 412 · see citing works

Neurotoxicity profiles of substituted amphetamines in the C57BL/6J mouse.

O'Callaghan, J. P., & Miller, D. B. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22433-8 · Cited by 409 · see citing works

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease

Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404 · see citing works

Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 393 · see citing works

The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic System

Herrera, A. J., Castaño, A., Venero, J. L., Cano, J., & Machado, A. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0289 · Cited by 392 · see citing works

Stress-induced elevation of glucocorticoids increases microglia proliferation through NMDA receptor activation

Nair, A., & Bonneau, R. H. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.09.012 · Cited by 392 · see citing works

Peripheral and central effects of circulating catecholamines

William Tank, A., & Lee Wong, D. (2014) · Comprehensive physiology · doi:10.1002/cphy.c140007 · Cited by 387 · see citing works

Forebrain Pathways Mediating Stress-Induced Hormone Secretion

de Kar, L. D. V., & Blair, M. L. (1999) · Frontiers in Neuroendocrinology · doi:10.1006/frne.1998.0172 · Cited by 380 · see citing works

Charting of Type II glucocorticoid receptor-like immunoreactivity in the rat central nervous system

Ahima, R. S., & Harlan, R. E. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90244-x · Cited by 360 · see citing works

Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease

Koprich, J. B., Reske-Nielsen, C., Mithal, P., & Isacson, O. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-8 · Cited by 355 · see citing works

Genomic investigation of α‐synuclein multiplication and parkinsonism

Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J. M., Hulihan, M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 341 · see citing works

Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's disease

Wilms, H., Rosenstiel, P. C., Sievers, J., Deuschl, G., Zecca, L., & Lucius, R. (2003) · The FASEB Journal · doi:10.1096/fj.02-0314fje · Cited by 337 · see citing works

Alterations of T-lymphocyte populations in Parkinson disease

Baba, Y., Kuroiwa, A., Uitti, R. J., Wszolek, Z. K., & Yamada, T. (2005) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2005.07.005 · Cited by 336 · see citing works

Twenty-Four Hour Cortisol Release Profiles in Patients With Alzheimer's and Parkinson's Disease Compared to Normal Controls: Ultradian Secretory Pulsatility and Diurnal Variation

Hartmann, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)80309-0 · Cited by 319 · see citing works

Methamphetamine Neurotoxicity in Dopamine Nerve Endings of the Striatum Is Associated with Microglial Activation

Thomas, D. M., Walker, P. D., Benjamins, J. A., Geddes, T. J., & Kuhn, D. M. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.070961 · Cited by 315 · see citing works

Stress and glucocorticoid receptor-dependent mechanisms in long-term memory: From adaptive responses to psychopathologies

Finsterwald, C., & Alberini, C. M. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.09.017 · Cited by 311 · see citing works

Long-term methamphetamine induced changes in brain catecholamines in tolerant rhesus monkeys

Seiden, L. S., Fischman, M. W., & Schuster, C. R. (1976) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(76)90030-2 · Cited by 307 · see citing works

Prior exposure to glucocorticoids sensitizes the neuroinflammatory and peripheral inflammatory responses to E. coli lipopolysaccharide

Frank, M. G., Miguel, Z. D., Watkins, L. R., & Maier, S. F. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.008 · Cited by 303 · see citing works

α‐Synuclein oligomers and clinical implications for Parkinson disease

Kalia, L. V., Kalia, S. K., McLean, P. J., Lozano, A. M., & Lang, A. E. (2012) · Annals of Neurology · doi:10.1002/ana.23746 · Cited by 295 · see citing works

Acute Stress Increases Depolarization-Evoked Glutamate Release in the Rat Prefrontal/Frontal Cortex: The Dampening Action of Antidepressants

Musazzi, L., Milanese, M., Farisello, P., Zappettini, S., Tardito, D., Barbiero, V. S., Bonifacino, T., Mallei, A., Baldelli, P., Racagni, G., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008566 · Cited by 288 · see citing works

Alpha-synuclein: from secretion to dysfunction and death

Marques, O., & Outeiro, T. F. (2012) · Cell Death and Disease · doi:10.1038/cddis.2012.94 · Cited by 287 · see citing works

Glucocorticoid toxicity in the hippocampus: reversal by supplementation with brain fuels

Sapolsky, R. (1986) · Journal of Neuroscience · doi:10.1523/jneurosci.06-08-02240.1986 · Cited by 284 · see citing works

The resolution of inflammation: Anti-inflammatory roles for NF-κB

Lawrence, T., & Fong, C. H.-Y. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.12.016 · Cited by 283 · see citing works

Chronic Unpredictable Stress Exacerbates Lipopolysaccharide-Induced Activation of Nuclear Factor-κB in the Frontal Cortex and Hippocampus via Glucocorticoid Secretion

Munhoz, C. D., Lepsch, L. B., Kawamoto, E. M., Malta, M. B., Lima, L. D. S., Werneck Avellar, M. C., Sapolsky, R. M., & Scavone, C. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4398-05.2006 · Cited by 274 · see citing works

IL‐1: Discoveries, controversies and future directions

Dinarello, C. A. (2010) · European Journal of Immunology · doi:10.1002/eji.201040319 · Cited by 270 · see citing works

Increased risk of Parkinson’s disease after depression

Schuurman, A. G., van den Akker, M., Ensinck, K., Metsemakers, J. F. M., Knottnerus, J. A., Leentjens, A. F. G., & Buntinx, F. (2002) · Neurology · doi:10.1212/wnl.58.10.1501 · Cited by 270 · see citing works

Prior Stressor Exposure Sensitizes LPS-Induced Cytokine Production

Johnson, J. D., O'Connor, K. A., Deak, T., Stark, M., Watkins, L. R., & Maier, S. F. (2002) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2001.0638 · Cited by 270 · see citing works

Glucocorticoids sensitize the innate immune system through regulation of the NLRP3 inflammasome

Busillo, J. M., Azzam, K. M., & Cidlowski, J. A. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.275370 · Cited by 264 · see citing works

From shell shock and war neurosis to posttraumatic stress disorder: a history of psychotraumatology

Crocq, M., & Crocq, L. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.1/macrocq · Cited by 263 · see citing works

Environment-, drug- and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J mouse.

Miller, D. B., & O'Callaghan, J. P. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22434-x · Cited by 261 · see citing works

The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh‐TNF‐α, IL‐1β and IFN‐γ

Castaño, A., Herrera, A. J., Cano, J., & Machado, A. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 239 · see citing works

Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement

Espay, A. J., LeWitt, P. A., & Kaufmann, H. (2014) · Movement Disorders · doi:10.1002/mds.26048 · Cited by 237 · see citing works

Stress sounds the alarmin: The role of the danger-associated molecular pattern HMGB1 in stress-induced neuroinflammatory priming

Frank, M. G., Weber, M. D., Watkins, L. R., & Maier, S. F. (2015) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2015.03.010 · Cited by 237 · see citing works

Inflammation and α-Synuclein’s Prion-like Behavior in Parkinson's Disease—Is There a Link?

Tomé, C. M. L., Tyson, T., Rey, N. L., Grathwohl, S. A., Britschgi, M., & Brundin, P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8267-8 · Cited by 237 · see citing works

Evidence That the Peptidylprolyl Isomerase Domain of the hsp90-binding Immunophilin FKBP52 Is Involved in Both Dynein Interaction and Glucocorticoid Receptor Movement to the Nucleus

Galigniana, M. D., Radanyi, C., Renoir, J.-M., Housley, P. R., & Pratt, W. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010809200 · Cited by 236 · see citing works

Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases

Levite, M. (2015) · Acta Physiologica · doi:10.1111/apha.12476 · Cited by 236 · see citing works

Progressive neurodegeneration and motor disabilities induced by chronic expression of IL-1β in the substantia nigra

Ferrari, C. C., Pott Godoy, M. C., Tarelli, R., Chertoff, M., Depino, A. M., & Pitossi, F. J. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.06.013 · Cited by 235 · see citing works

Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism

Ros-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017820108 · Cited by 231 · see citing works

Stress, depression and Parkinson's disease

Hemmerle, A. M., Herman, J. P., & Seroogy, K. B. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2011.09.035 · Cited by 225 · see citing works

Molecular Control of Immune/Inflammatory Responses: Interactions Between Nuclear Factor- B and Steroid Receptor-Signaling Pathways

McKay, L. I. (1999) · Endocrine Reviews · doi:10.1210/er.20.4.435 · Cited by 223 · see citing works

Stress Induces the Danger-Associated Molecular Pattern HMGB-1 in the Hippocampus of Male Sprague Dawley Rats: A Priming Stimulus of Microglia and the NLRP3 Inflammasome

Weber, M. D., Frank, M. G., Tracey, K. J., Watkins, L. R., & Maier, S. F. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.3561-14.2015 · Cited by 215 · see citing works

Stress increases vulnerability to inflammation in the rat prefrontal cortex

de Pablos, R. M., Villarán, R. F., Argüelles, S., Herrera, A. J., Venero, J. L., Ayala, A., Cano, J., & Machado, A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0802-06.2006 · Cited by 215 · see citing works

Aging, stress and the hippocampus

Miller, D. B., & O’Callaghan, J. P. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.002 · Cited by 206 · see citing works

Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease

Zecca, L., Wilms, H., Geick, S., Claasen, J.-H., Brandenburg, L.-O., Holzknecht, C., Panizza, M. L., Zucca, F. A., Deuschl, G., Sievers, J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0361-7 · Cited by 205 · see citing works

Minocycline Reduces the Lipopolysaccharide-Induced Inflammatory Reaction, Peroxynitrite-Mediated Nitration of Proteins, Disruption of the Blood–Brain Barrier, and Damage in the Nigral Dopaminergic System

Tomás-Camardiel, M., Rite, I., Herrera, A. J., de Pablos, R. M., Cano, J., Machado, A., & Venero, J. L. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.01.010 · Cited by 203 · see citing works

Influence of Arousal and Attention on the Control of Postural Sway1

Maki, B. E., & McIlroy, W. E. (1996) · Journal of Vestibular Research · doi:10.3233/ves-1996-6107 · Cited by 202 · see citing works

Chronic Stress Enhances Microglia Activation and Exacerbates Death of Nigral Dopaminergic Neurons under Conditions of Inflammation

de Pablos, R. M., Herrera, A. J., Espinosa-Oliva, A. M., Sarmiento, M., Muñoz, M. F., Machado, A., & Venero, J. L. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-34 · Cited by 201 · see citing works

Adverse Stress, Hippocampal Networks, and Alzheimer’s Disease

Rothman, S. M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8107-9 · Cited by 197 · see citing works

The long-term effects of multiple doses of methamphetamine on neostriatal trypthophan hydroxylase, tyrosine hydroxylase, choline acetyltransferase and glutamate decarboxylase activities

Hotchkiss, A. J., Morgan, M. E., & Gibb, J. W. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90414-4 · Cited by 191 · see citing works

Glucocorticoids Play a Fundamental Role in Protecting the Brain during Innate Immune Response

Nadeau, S., & Rivest, S. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-13-05536.2003 · Cited by 190 · see citing works

Therapeutic approaches to inflammation in neurodegenerative disease

Klegeris, A., McGeer, E. G., & McGeer, P. L. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3280adc943 · Cited by 186 · see citing works

Chronic exposure to exogenous glucocorticoids primes microglia to pro-inflammatory stimuli and induces NLRP3 mRNA in the hippocampus

Frank, M. G., Hershman, S. A., Weber, M. D., Watkins, L. R., & Maier, S. F. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.006 · Cited by 183 · see citing works

Depression and anxiety related subtypes in Parkinson's disease

Brown, R. G., Landau, S., Hindle, J. V., Playfer, J., Samuel, M., Wilson, K. C., Hurt, C. S., Anderson, R. J., Carnell, J., Dickinson, L., et al. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2010.213652 · Cited by 183 · see citing works

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's Disease

Menza, M. A., Dobkin, R. D., Marín, H., Mark, M. H., Gara, M. A., Bienfait, K., Dicke, A., & Kusnekov, A. (2010) · Psychosomatics · doi:10.1016/s0033-3182(10)70739-8 · Cited by 182 · see citing works

Novel glucocorticoid effects on acute inflammation in the CNS

Dinkel, K., MacPherson, A., & Sapolsky, R. M. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01604.x · Cited by 179 · see citing works

Novel Roles for Caspase-8 in IL-1β and Inflammasome Regulation

Gurung, P., & Kanneganti, T. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.08.025 · Cited by 178 · see citing works

Glucocorticoids and Tumor Necrosis Factor Alpha Cooperatively Regulate Toll-Like Receptor 2 Gene Expression

Hermoso, M. A., Matsuguchi, T., Smoak, K. A., & Cidlowski, J. A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4743-4756.2004 · Cited by 177 · see citing works

Serotonin and Parkinson's disease: On movement, mood, and madness

Fox, S. H., Chuang, R., & Brotchie, J. M. (2009) · Movement Disorders · doi:10.1002/mds.22473 · Cited by 174 · see citing works

Substantial reduction of naïve and regulatory T cells following traumatic stress

Sommershof, A., Aichinger, H., Engler, H., Adenauer, H., Catani, C., Boneberg, E.-M., Elbert, T., Groettrup, M., & Kolassa, I.-T. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.07.003 · Cited by 172 · see citing works

The relation between α-synuclein and microglia in Parkinson’s disease: Recent developments

Sánchez-Guajardo, V., Tentillier, N., & Romero‐Ramos, M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.02.008 · Cited by 171 · see citing works

α-Synuclein Overexpression Increases Cytosolic Catecholamine Concentration

Mosharov, E. V., Staal, R. G. W., Bové, J., Prou, D., Hananiya, A., Markov, D., Poulsen, N., Larsen, K. E., Moore, C. M. H., Troyer, M. D., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0519-06.2006 · Cited by 165 · see citing works

Forced swimming test in rats: effect of desipramine administration and the period of exposure to the test on struggling behavior, swimming, immobility and defecation rate

Armario, A., Gavaldà, A., & Martı́, O. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90068-4 · Cited by 155 · see citing works

Glucocorticoids Exacerbate Kainic Acid–Induced Extracellular Accumulation of Excitatory Amino Acids in the Rat Hippocampus

Stein-Behrens, B., Elliott, E. M., Miller, C. A., Schilling, J. W., Newcombe, R. G., & Sapolsky, R. M. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10047.x · Cited by 151 · see citing works

Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus

Espinosa-Oliva, A. M., de Pablos, R. M., Villarán, R. F., Argüelles, S., Venero, J. L., Machado, A., & Cano, J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.01.012 · Cited by 151 · see citing works

Modulation of motor function by stress: a novel concept of the effects of stress and corticosterone on behavior

Metz, G. A. S., Jadavji, N. M., & Smith, L. K. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04285.x · Cited by 151 · see citing works

Inflammatory Cytokine Gene Polymorphisms and Increased Risk of Parkinson Disease

Wahner, A. D., Sinsheimer, J. S., Bronstein, J. M., & Ritz, B. R. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.836 · Cited by 143 · see citing works

Depression and somatization in the chronic fatigue syndrome

Lane, T. J., Manu, P., & Matthews, D. A. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90150-v · Cited by 139 · see citing works

Effects of prior stress on LPS-induced cytokine and sickness responses

Johnson, J. D., O'Connor, K. A., Hansen, M. K., Watkins, L. R., & Maier, S. F. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00230.2002 · Cited by 138 · see citing works

Functional implications of brain corticosteroid receptor diversity

de Kloet, E. D., Oitzl, M. S., & Joëls, M. (1993) · Cellular and molecular neurobiology · doi:10.1007/bf00711582 · Cited by 135 · see citing works

A review on animal models for screening potential anti-stress agents

Jaggi, A. S., Bhatia, N., Kumar, N., Singh, N., Anand, P., & Dhawan, R. K. (2011) · Neurological Sciences · doi:10.1007/s10072-011-0770-6 · Cited by 134 · see citing works

Methamphetamine-induced neurotoxicity is attenuated in transgenic mice with a null mutation for interleukin-6

Ladenheim, B., Krasnova, I. N., Deng, X., Oyler, J. M., Polettini, A., Moran, T. H., Huestis, M. A., & Cadet, J. L. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.6.1247 · Cited by 131 · see citing works

Stress‐induced neurological impairments in an animal model of parkinsonism

Snyder, A. M., Stricker, E. M., & Zigmond, M. J. (1985) · Annals of Neurology · doi:10.1002/ana.410180506 · Cited by 128 · see citing works

Stress accelerates neural degeneration and exaggerates motor symptoms in a rat model of Parkinson's disease

Smith, L. K., Jadavji, N. M., Colwell, K. L., Perehudoff, K. S., & Metz, G. A. S. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06177.x · Cited by 128 · see citing works

and Alzheimer's disease

Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125 · see citing works

Glucocorticoids worsen excitotoxin-induced expression of pro-inflammatory cytokines in hippocampal cultures

MacPherson, A., Dinkel, K., & Sapolsky, R. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.02.021 · Cited by 120 · see citing works

Association of interleukin-1β polymorphisms with idiopathic Parkinson's disease

McGeer, P. L., Yasojima, K., & McGeer, E. G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00300-2 · Cited by 118 · see citing works

Dissociation between adrenocorticotropin and corticosterone responses to restraint after previous chronic exposure to stress

Armario, A., Restrepo, C., Castellanos, J. M., & Balasch, J. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90304-2 · Cited by 116 · see citing works

Blood-brain barrier disruption highly induces aquaporin-4 mRNA and protein in perivascular and parenchymal astrocytes: Protective effect by estradiol treatment in ovariectomized animals

Tomás‐Camardiel, M., Venero, J. L., Herrera, A. J., de Pablos, R. M., Pintor‐Toro, J. A., Machado, A., & Cano, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20443 · Cited by 116 · see citing works

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson's Disease

Menza, M., Dobkin, R. D., Marin, H., et al. (2010) · Psychosomatics · doi:10.1176/appi.psy.51.6.474 · Cited by 116 · see citing works

Effects of Mood, Motivation, Stress and Alertness on the Performance in Parkinson's Disease

Schwab, R. S., & Zieper, I. (2008) · Psychiatria et Neurologia · doi:10.1159/000127780 · Cited by 112 · see citing works

Stress-induced Parkinson's disease: a working hypothesis

SMITH, A., Castro, S., & Zigmond, M. J. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00939-3 · Cited by 110 · see citing works

Fatigue in Parkinson's disease

Friedman, J. H., Abrantes, A. M., & Sweet, L. H. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.587120 · Cited by 107 · see citing works

The role of IL-1β in stress-induced sensitization of proinflammatory cytokine and corticosterone responses

Johnson, J. D., O’Connor, K., Watkins, L. R., & Maier, S. F. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.05.046 · Cited by 107 · see citing works

Stress downregulates lipopolysaccharide-induced expression of proinflammatory cytokines in the spleen, pituitary, and brain of mice

Goujon, E., Parnet, P., Laye, S., Combe, C., Kelley, K. W., & Dantzer, R. (1995) · Brain Behavior and Immunity · doi:10.1006/brbi.1995.1028 · Cited by 106 · see citing works

Can stress trigger Parkinson's disease?

Djamshidian, A., & Lees, A. J. (2013) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2013-305911 · Cited by 105 · see citing works

Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease

Schulte, T., Schöls, L. J., Müller, T. H., Woitalla, D., Berger, K., & Krüger, R. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00301-4 · Cited by 104 · see citing works

Psychobiology of Coping and Defence Strategies

Ursin, H., & Olff, M. (2008) · Neuropsychobiology · doi:10.1159/000119002 · Cited by 103 · see citing works

Corticosteroid Receptor Types in Brain: Regulation and Putative Functiona

de Kloet, E. R., Ratka, A., Reul, J. M. H. M., Sutanto, W., & EEKELEN, J. A. M. V. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24973.x · Cited by 102 · see citing works

Hsp90-binding immunophilins in plants: the protein movers

Pratt, W. B., Krishna, P., & Olsen, L. J. (2001) · Trends in Plant Science · doi:10.1016/s1360-1385(00)01843-4 · Cited by 101 · see citing works

The effects of acute and chronic stress on motor and sensory performance in male Lewis rats

Metz, G. A. S., Schwab, M. E., & Welzl, H. (2001) · Physiology & Behavior · doi:10.1016/s0031-9384(00)00371-1 · Cited by 100 · see citing works

Cortisol is higher in parkinsonism and associated with gait deficit

Charlett, A., Dobbs, R. J., Purkiss, A. G., Wrighe, D. J., Peterson, D. W., Weller, C., & Dobbs, S. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00614.x · Cited by 98 · see citing works

Competing targets of microRNA-608 affect anxiety and hypertension

Hanin, G., Shenhar‐Tsarfaty, S., Yayon, N., Yau, Y. H., Bennett, E. R., Sklan, E. H., Rao, D. C., Rankinen, T., Bouchard, C., Shochat, S. G., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu170 · Cited by 97 · see citing works

The Molecular Chaperones Hsp90 and Hsc70 Are Both Necessary and Sufficient to Activate Hormone Binding by Glucocorticoid Receptor

Rajapandi, T., Greene, L. E., & Eisenberg, E. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002035200 · Cited by 96 · see citing works

Transmembrane tumour necrosis factor is neuroprotective and regulates experimental autoimmune encephalomyelitis via neuronal nuclear factor-κB

Taoufik, E., Tseveleki, V., Chu, S. Y., Tselios, T. V., Karin, M., Lassmann, H., Szymkowski, D. E., & Probert, L. (2011) · Brain · doi:10.1093/brain/awr203 · Cited by 94 · see citing works

Blocking toll-like receptor 2 and 4 signaling during a stressor prevents stress-induced priming of neuroinflammatory responses to a subsequent immune challenge

Weber, M. D., Frank, M. G., Sobesky, J. L., Watkins, L. R., & Maier, S. F. (2013) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2013.03.004 · Cited by 93 · see citing works

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease

Krüger, R., Hardt, C., Tschentscher, F., Jäckel, S., Kuhn, W., Müller, T., Werner, J., Woitalla, D., Berg, D., Kühnl, N., et al. (2000) · Journal of Neural Transmission · doi:10.1007/s007020070078 · Cited by 93 · see citing works

Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide

Hernández-Romero, M. C., Argüelles, S., Villarán, R. F., de Pablos, R. M., Delgado‐Cortés, M. J., Santiago, M., Herrera, A. J., Cano, J., & Machado, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05148.x · Cited by 91 · see citing works

Inhibition of microglial cell activation by cortisol

Drew, P. D., & Chavis, J. A. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(00)00275-6 · Cited by 88 · see citing works

Occupation and parkinsonism in three movement disorders clinics

Goldman, S. M., Tanner, C. M., Olanow, C. W., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000180361.74060.70 · Cited by 87 · see citing works

Chronic exposure to corticosterone enhances the neuroinflammatory and neurotoxic responses to methamphetamine

Kelly, K. A., Miller, D. B., Bowyer, J. F., & O'Callaghan, J. P. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07864.x · Cited by 82 · see citing works

Dopamine receptor agonists in the therapy of Parkinson?s disease

Foley, P., Gerlach, M., Double, K. L., et al. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-003-0059-x · Cited by 81 · see citing works

MK-801 and 7-Ni attenuate the activation of brain NF-κB induced by LPS

Glezer, I., Munhoz, C. D., Kawamoto, E. M., Marcourakis, T., Avellar, M. C. W., & Scavone, C. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00279-x · Cited by 79 · see citing works

Dopamine-derived Quinones Affect the Structure of the Redox Sensor DJ-1 through Modifications at Cys-106 and Cys-53

Girotto, S., Sturlese, M., Bellanda, M., Tessari, I., Cappellini, R., Bisaglia, M., Bubacco, L., & Mammi, S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.311589 · Cited by 73 · see citing works

Glucocorticoid pretreatment induces cytokine overexpression and nuclear factor-κB activation in macrophages

Smyth, G. P., Stapleton, P. P., Freeman, T. A., Concannon, E. M., Mestre, J. R., Duff, M., Maddali, S., & Daly, J. M. (2004) · Journal of Surgical Research · doi:10.1016/s0022-4804(03)00300-7 · Cited by 72 · see citing works

Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide

Morale, M. C., Serra, P. A., Delogu, M. R., Migheli, R., Rocchitta, G., Tirolo, C., Caniglia, S., Testa, N., L’Episcopo, F., Gennuso, F., et al. (2003) · The FASEB Journal · doi:10.1096/fj.03-0501fje · Cited by 71 · see citing works

Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia

Carreño‐Müller, E., Herrera, A. J., de Pablos, R. M., Tomás‐Camardiel, M., Venero, J. L., Cano, J., & Machado, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01634.x · Cited by 70 · see citing works

Neuromelanin activates proinflammatory microglia through a caspase-8-dependent mechanism

Viceconte, N., Burguillos, M. Á., Herrera, A. J., de Pablos, R. M., Joseph, B., & Venero, J. L. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-014-0228-x · Cited by 61 · see citing works

Sex differences in rats: Effects of chronic stress on sympathetic system and anxiety

Renard, G. M., Suárez, M. M., Levin, G. M., & Rivarola, M. A. (2005) · Physiology & Behavior · doi:10.1016/j.physbeh.2005.05.003 · Cited by 56 · see citing works

Neurodevelopmental origin and adult neurogenesis of the neuroendocrine hypothalamus

Maggi, R., Zasso, J., & Conti, L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00440 · Cited by 55 · see citing works

INHIBITION OF MICROGLIAL SUPEROXIDE ANION PRODUCTION BY ISOPROTERENOL AND DEXAMETHASONE

Colton, C. A., & Chernyshev, O. N. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00139-5 · Cited by 51 · see citing works

Depressive illness in Parkinson’s disease – indication of a more advanced and widespread neurodegenerative process?

Pålhagen, S., Carlsson, M., Curman, E., Wålinder, J., & Granérus, A. (2008) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2007.00986.x · Cited by 51 · see citing works

Polymorphisms in immune/inflammatory cytokine genes are related to Parkinson's disease with cognitive impairment in the Han Chinese population

Nie, K., Zhang, Y., Gan, R., Wang, L., Zhao, J., Huang, Z., Tang, H., & Wang, L. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.02.024 · Cited by 49 · see citing works

Tumor necrosis factor‐α promoter polymorphism is associated with the risk of Parkinson's disease

Wu, Y., Feng, I., Lyu, R., Chang, K., Lin, Y., Chan, H., Hu, F.-J., Lee‐Chen, G., & Chen, C. (2006) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30435 · Cited by 49 · see citing works

Melanin affinity and its possible role in neurodegeneration

Karlsson, O., & Lindquist, N. G. (2013) · Journal of Neural Transmission · doi:10.1007/s00702-013-1062-5 · Cited by 45 · see citing works

Dopamine‐dependent neurotoxicity of lipopolysaccharide in substantia nigra

de Pablos, R. M., Herrera, A. J., Villarán, R. F., Cano, J., & Machado, A. (2004) · The FASEB Journal · doi:10.1096/fj.04-2153fje · Cited by 45 · see citing works

Advanced microarray analysis highlights modified neuro-immune signaling in nucleated blood cells from Parkinson's disease patients

Soreq, L., Israel, Z. H., Bergman, H., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.06.019 · Cited by 43 · see citing works

Dexamethasone selectively suppresses microglial trophic responses to hippocampal deafferentation

Woods, A. G., Poulsen, F. R., & Gall, C. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00685-x · Cited by 43 · see citing works

Gait abnormalities in chronic fatigue syndrome

Boda, W. L., Natelson, B. H., Sisto, S. A., et al. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00108-e · Cited by 34 · see citing works

Psychosocial risk factors, pre‐motor symptoms and first‐time hospitalization with P arkinson's disease: a prospective cohort study

Clark, A. J., Ritz, B. R., Prescott, E., & Rod, N. H. (2013) · European Journal of Neurology · doi:10.1111/ene.12117 · Cited by 30 · see citing works

Shell shock at Queen Square: Lewis Yealland 100 years on

Linden, S. C., Jones, E., & Lees, A. J. (2013) · Brain · doi:10.1093/brain/aws331 · Cited by 30 · see citing works

Risk factors for dementia in Parkinson's disease.

Salganik, I., & Korczyn, A. D. (1990) · PubMed · Cited by 30 · see citing works

Associative processes in adaptation to repeated cold exposure in rats.

Riccio, D. C., MacArdy, E. A., & Kissinger, S. C. (1991) · Behavioral Neuroscience · doi:10.1037//0735-7044.105.4.599 · Cited by 29 · see citing works

Differential Regulation of CuZnSOD Expression in Rat Brain by Acute and/or Chronic Stress

Filipović, D., & Pajović, S. B. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9375-5 · Cited by 28 · see citing works

Acute Levodopa Intake and Associated Cortisol Decrease in Patients With Parkinson Disease

Müller, T. H., & Muhlack, S. (2007) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000240954.72186.91 · Cited by 25 · see citing works

Stress affects hedonic responses but not reaching-grasping in Parkinson's disease

Macht, M. L., Brandstetter, S., & Ellgring, H. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.10.032 · Cited by 24 · see citing works

In altering the release of glucocorticoids, ketorolac exacerbates the effects of systemic immune stimuli on expression of proinflammatory genes in the brain

Blais, V., Zhang, J., & Rivest, S. (2002) · Endocrinology · doi:10.1210/en.2002-220598 · Cited by 22 · see citing works

Major life events and risk of Parkinson's disease

Rod, N. H., Hansen, J., Schernhammer, E. S., et al. (2010) · Movement Disorders · doi:10.1002/mds.22850 · Cited by 22 · see citing works

The intranigral injection of tissue plasminogen activator induced blood–brain barrier disruption, inflammatory process and degeneration of the dopaminergic system of the rat

Villarán, R. F., de Pablos, R. M., Argüelles, S., Espinosa‐Oliva, A. M., Tomás‐Camardiel, M., Herrera, A. J., Cano, J., & Machado, A. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.02.011 · Cited by 21 · see citing works

Parkinson's disease and motor-neuron disease in former prisoners-of-war

Page, W. F., & Tanner, C. M. (2000) · The Lancet · doi:10.1016/s0140-6736(05)72455-7 · Cited by 21 · see citing works

A case of early onset Parkinson's disease after major stress

Zheng, Z. S., Zou, K., Guo, W., Tang, G., & Zheng, B. (2013) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s48455 · Cited by 21 · see citing works

Associative processes in adaptation to repeated cold exposure in rats.

Riccio, D. C., MacArdy, E. A., & Kissinger, S. C. (1991) · Behavioral Neuroscience · doi:10.1037/0735-7044.105.4.599 · Cited by 21 · see citing works

Type II Corticosteroid Receptor-Like Immunoreactivity in the Rat Cerebellar Cortex: Differential Regulation by Corticosterone

Ahima, R. S., Tagoe, C. N. B., & Harlan, R. E. (2008) · Neuroendocrinology · doi:10.1159/000126188 · Cited by 19 · see citing works

Degeneration of dopaminergic neurons induced by thrombin injection in the substantia nigra of the rat is enhanced by dexamethasone: Role of monoamine oxidase enzyme

Argüelles, S., Herrera, A. J., Carreño‐Müller, E., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Machado, A., & Cano, J. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.12.001 · Cited by 19 · see citing works

Alterations in Vagal-Immune Pathway in Long-Lasting Mental Stress

Višňovcová, Z., Mokrá, D., Mikolka, P., Mestanik, M., Jurko, A., Javorka, M., Čalkovská, A., & Tonhajzerová, I. (2014) · Advances in experimental medicine and biology · doi:10.1007/5584_2014_10 · Cited by 11 · see citing works

Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson’s disease

Müller, T. H., & Muhlack, S. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0018-7 · Cited by 11 · see citing works

Learning to cope with repeated stress

Leng, G., & Russell, J. A. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.331bk.x · Cited by 9 · see citing works

Is elevated norepinephrine an etiological factor in some cases of Parkinson’s disease?

Fitzgerald, P. J. (2014) · Medical Hypotheses · doi:10.1016/j.mehy.2014.01.026 · Cited by 9 · see citing works

Mental Hygiene

SALMON, T. W. (2006) · American Journal of Public Health · doi:10.2105/ajph.96.10.1740 · Cited by 7 · see citing works

Differential expression of voltage-gated Ca2+ conductances in human neuroblastoma NB69 cells cultured in defined serum-free and astrocyte-conditioned media

Urbano, F. J., Sierra, F., Velasco, J. M., & Bu�o, W. (1997) · Glia · doi:10.1002/(sici)1098-1136(199705)20:1 · Cited by 3 · see citing works

Occupation and Risk of Parkinsonism

Tanner, C. M., Ross, G. W., Jewell, S. A., Hauser, R. A., Jankovic, J. J., Factor, S. A., Bressman, S., Deligtisch, A., Marras, C., Lyons, K. E., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.195 · Cited by 1 · see citing works

Microglia in physiology and disease

Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426 · see citing works

The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.

Ramirez, A. I., de Hoz, R., Salobrar-Garcia, E., Salazar, J. J., Rojas, B., Ajoy, D., López-Cuenca, I., Rojas, P., Triviño, A., & Ramírez, J. M. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00214 · Cited by 466 · see citing works

Microglia–blood vessel interactions: a double-edged sword in brain pathologies

Dudvarski Stankovic, N., Teodorczyk, M., Ploen, R., Zipp, F., & Schmidt, M. H. H. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1524-y · Cited by 301 · see citing works

Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation

Vieira, B. D. M., Radford, R. A., Chung, R. S., Guillemin, G. J., & Pountney, D. L. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00437 · Cited by 93 · see citing works

Contributions of Microglia in the Healthy and Injured Brain

Rice, R. A. (2015) · eScholarship (California Digital Library)

Microglia derived from the axotomized adult rat facial nucleus uptake glutamate and metabolize it to glutamine in vitro

Nakajima, K., Kanamatsu, T., Koshimoto, M., & Kohsaka, S. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.10.015 · Cited by 7 · see citing works

Microglia in multiple sclerosis: protectors turn destroyers

Yong, V. W. (2022) · Neuron · doi:10.1016/j.neuron.2022.06.023 · Cited by 185 · see citing works

Iron loading is a prominent feature of activated microglia in Alzheimer’s disease patients

Kenkhuis, B., Somarakis, A., de Haan, L., Dzyubachyk, O., IJsselsteijn, M. E., de Miranda, N. F. C. C., Lelieveldt, B. P. F., Dijkstra, J., van Roon-Mom, W. M. C., Höllt, T., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01126-5 · Cited by 184 · see citing works

Microglial Kv1.3 Channels as a Potential Target for Alzheimer's Disease

Jenkins, D. P., Maezawa, I., Wulff, H., et al. (2012) · The FASEB Journal · doi:10.1096/fasebj.26.1_supplement.695.16 · Cited by 1 · see citing works